Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflows
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced Biosyntia, a biotechnology company focused on synthetic biology and metabolic engineering, has adopted the Pico-Mine® platform within its workflows.
Plumis launches watermist suppression system installer competency framework
Plumis has launched a new training suite to demonstrate the competency of it watermist fire suppression system installers.
£800k grant awarded to find undiagnosed liver disease patients in UK health system using precision medicine
Grants totalling £800k have been awarded by Innovate UK to a group of applicants aiming to develop and test a system to identify undiagnosed, high-risk liver disease in patient populations.
Sano Genetics founder: Settling for the wrong funding can ‘torpedo’ your startup
Charlotte Guzzo is the co-founder and COO of Sano Genetics, a healthtech startup that connects patients that have rare and chronic diseases with personalised medicine providers.
Official opening of first commercial plant operating with the Enval technology
Enval Limited (Enval) the leading designer and constructor of decentralised, chemical recycling plants for flexible plastic packaging waste is delighted to announce that Greenback Recycling Technologies Ltd. (Greenback) has officially opened its first-of-a-kind recycling plant using the Enval™ technology.
Graphene-based semiconductor named among top UK innovations
Several technologies including an AI-based forecasting and risk management tool, and graphene sensors many times more sensitive and energy efficient than established silicon technology are competing to be named the UK’s leading engineering innovation.
University of Bristol spinout Albotherm lands £1.6m investment
University of Bristol spin-out Albotherm, whose innovative carbon-saving coating for commercial greenhouses could boost food production by a third, has secured a £1.6 million investment.
Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification.
University spin-out secures £500k from angels
Molymem is working with the Graphene Engineering Innovation Centre and will scale its technology platform and build its team
Computing platform developer Signaloid raises £3 million in a seed round led by IQ Capital
Signaloid's platform enables automatic tracking of real-world data variations, offering faster computation and risk reduction
Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategy
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the introduction of new branding to align with its ambitious global commercial growth strategy. The update has been introduced to better reflect the Company’s customer-centric approach and showcase its pioneering single cell discovery and analysis technology, following a period of significant growth and program success.
FocalPoint founder stresses the power of IP for any technology trailblazer
Cambridge-based DeepTech scale-up FocalPoint, which is on a mission to be in every single GPS chip on the planet, says its Supercorrelation™ technology is currently licensed to Swiss influencer u-blox among several international businesses and is in advanced trials with several major device manufacturers.
PharmEnable closes $7.5m funding round to scale drug hunt
PharmEnable, a Cambridge drug discovery company focused on chemical novelty, diversity and complexity, has closed a Pre-Series A investment round of $7.5 million to develop the next generation of small molecule drugs against disease areas of high clinical need.
Partners to use AI on clinical trial data to help advance care, therapies
Collaborators hope to discover prognostic markers for IPF, other ILDs
Closed Loop Medicine and Pharmanovia enter a co-development partnership for precision medicine combination therapeutics
Closed Loop Medicine Ltd, a leading TechBio company, developing combination prescription drug plus software therapy products that enable personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced that they have entered a global co-development partnership.
SSTL + Oxford Space Systems to launch the CarbSAR in orbit demo mission to showcase wrapped rib antenna
Surrey Satellite Technology Ltd. (SSTL) and Oxford Space Systems (OSS) have confirmed a partnership to build and launch an OSS Wrapped Rib antenna mounted to an SSTL CarbSAR satellite.
Funderbeam lands £31.7m for investor marketplace
Irish venture capital firm VentureWave has led a $40m (£31.7m) round into the investment site Funderbeam.
MicrofluidX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies
Joint research project with the goal of increasing efficiency and reducing cost of manufacture through precision process control
Paragraf’s California acquisition brings new electronics frontier ever closer
Graphene technology pathfinder Paragraf, which is expanding fast on both sides of the Atlantic, has strengthened still further with a key acquisition in San Diego.
Ken Hitchner Appointed as Board of Directors Chairman
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Kenneth Hitchner BA MBA as Chairman of its Board of Directors. The announcement follows a series of appointments to the Company’s senior leadership team, as part of its ambitious global growth strategy.